CMP* (Rs) 301 Upside/ (Downside) (%) 25. Market Cap. (Rs bn) 19.6 Free Float (%) 26 Shares O/S (mn) 65

Similar documents
CMP (Rs) 775 Upside/ (Downside) (%) (1.4) Market Cap. (Rs bn) 11.4 Free Float (%) 35.0 Shares O/S (mn) 14.7

BUY NCC. An Ordinary Quarterly Performance; Maintain BUY. Target Price: Rs98. Institutional Equity Research. 4QFY17 Result Update May 24, 2017

HOLD ACC. Strong Performance on Better Volume and Firm Realizations. Target Price: Rs1,640. Institutional Equity Research

CMP* (Rs) 840 Upside/ (Downside) (%) (2.4) Bloomberg Ticker Market Cap. (Rs bn) 379 Free Float (%) 53 Shares O/S (mn) 451.6

CMP* (Rs) 208 Upside/ (Downside) (%) 18. Market Cap. (Rs bn) Free Float (%) 65.6 Shares O/S (mn) 630

CMP* (Rs) 166 Upside/ (Downside) (%) 28 Bloomberg Ticker. NTPC IN Market Cap. (Rs bn) 1,361 Free Float (%) 37.7 Shares O/S (mn) 8,245

Nestlé India Outlook Hazy; Valuations Prohibitive

CMP* (Rs) 242 Upside/ (Downside) (%) 2. Market Cap. (Rs bn) 157 Free Float (%) 65.6 Shares O/S (mn) 630

CMP* (Rs) 1,458 Upside/ (Downside) (%) 10 Bloomberg Ticker. ABB IN Market Cap. (Rs bn) 309 Free Float (%) 25 Shares O/S (mn) 212

CMP* (Rs) 346 Upside/ (Downside) (%) 17. Market Cap. (Rs bn) 23 Free Float (%) 42.0 Shares O/S (mn) 67

HOLD. Nestle. Good Performance Irrespective of GST Pangs. Target Price: Rs6,624. Institutional Equity Research. 2QCY17 Result Update July 27,2017

CMP (Rs) 326 Upside/ (Downside) (%) 24. Market Cap. (Rs bn) 21.7 Free Float (%) 42.0 Shares O/S (mn) 67

CMP* (Rs) 417 Upside/ (Downside) (%) 46 Bloomberg Ticker. SUNP IN Market Cap. (Rs bn) 1,001 Free Float (%) 46 Shares O/S (mn) 2399

Titan Company BUY. Back to Value Zone Validate Rating Upgrade. Institutional Equity Research. November 05, Target Price Rs428.

CMP* (Rs) 336 Upside/ (Downside) (%) 21 Bloomberg Ticker. MOIL IN Market Cap. (Rs bn) 45 Free Float (%) 24 Shares O/S (mn) 133

CMP* (Rs) 263 Upside/ (Downside) (%) 7.3. Market Cap. (Rs bn) 635 Free Float (%) 59 Shares O/S (mn) 2,417

CMP* (Rs) 203 Upside/ (Downside) (%) 23. Market Cap. (Rs bn) 116 Free Float (%) 61 Shares O/S (mn) 572

KNR Constructions Robust Performance on Execution Ramp-up

CMP* (Rs) 205 Upside/ (Downside) (%) 12 Bloomberg Ticker. NACO IN Market Cap. (Rs bn) 29 Free Float (%) 27 Shares O/S (mn) 143

CMP* (Rs) 161 Upside/ (Downside) (%) 19 Bloomberg Ticker. NTPC IN Market Cap. (Rs bn) 1,329 Free Float (%) 30.3 Shares O/S (mn) 8,245

CMP* (Rs) 1,033 Upside/ (Downside) (%) (0.3) Bloomberg Ticker Market Cap. (Rs bn) 467 Free Float (%) 53 Shares O/S (mn) 452

CMP* (Rs) 360 Upside/ (Downside) (%) 25. Market Cap. (Rs bn) 38 Free Float (%) 76 Shares O/S (mn) 104.5

CMP* (Rs) 237 Upside/ (Downside) (%) 29 Bloomberg Ticker. APTY IN Market Cap. (Rs bn) 136 Free Float (%) 55.9 Shares O/S (mn) 509

CMP* (Rs) 172 Upside/ (Downside) (%) 11.6 Bloomberg Ticker. NTPC IN Market Cap. (Rs bn) 1,414 Free Float (%) 30.3 Shares O/S (mn) 8,245

CMP* (Rs) 1,424 Upside/ (Downside) (%) 19 Bloomberg Ticker Market Cap. (Rs bn) 268 Free Float (%) 46 Shares O/S (mn) 188

BUY CDSL. Strong Operating Performance; Maintain BUY. Target Price: Rs435. Institutional Equity Research. 2QFY18 Result Update October 31, 2017

CMP* (Rs) 1,464 Upside/ (Downside) (%) 10. Market Cap. (Rs bn) 91 Free Float (%) 55 Shares O/S (mn) 62

CMP (Rs) 702 Upside/ (Downside) (%) 42 Bloomberg Ticker. JKCE IN Market Cap. (Rs bn) 54 Free Float (%) 42 Shares O/S (mn) 77.3

CMP (Rs) 249 Upside/ (Downside) (%) Market Cap. (Rs bn) 25.5 Free Float (%) 29.7 Shares O/S (mn) 102.3

BUY NTPC. Higher Regulated Equity to Aid Profitability; Maintain BUY. Target Price: Rs192. Institutional Equity Research

CMP (Rs) 133 Upside/ (Downside) (%) 35 Bloomberg Ticker. ICEM IN Market Cap. (Rs bn) 41 Free Float (%) 71.6 Shares O/S (mn) 308.1

BUY. DCB Bank. Improving Capital Consumption to Aid Returns; Maintain BUY. Target Price: Rs202. Institutional Equity Research

CMP* (Rs) 145 Upside/ (Downside) (%) 32 Bloomberg Ticker BOB IN Market Cap. (Rs bn) 384 Free Float (%) 36 Shares O/S (mn) 2,646

CMP* (Rs) 289 Upside/ (Downside) (%) 18. Market Cap. (Rs bn) 30 Free Float (%) 69 Shares O/S (mn) 105

KEC International. Recovering from a weak phase. Institutional Equity Research. Order inflow traction remains intact

CMP* (Rs) 189 Upside/ (Downside) (%) (1) Bloomberg Ticker PNB IN Market Cap. (Rs bn) 402 Free Float (%) 38 Shares O/S (mn) 2,128

Sonata Software HOLD. Unimpressive Show; IITS Revenue Disappoints. Institutional Equity Research. February 06, Target Price Rs190.

CMP* (Rs) 198 Upside/ (Downside) (%) 12. Market Cap. (Rs bn) 61 Free Float (%) 84 Shares O/S (mn) 308

Aurobindo Pharma. Institutional Equity Research. Sector - Pharmaceuticals. RSec TradEdge India. March 02, 2017

CMP (Rs) 166 Upside/ (Downside) (%) (1) Bloomberg Ticker Market Cap. (Rs bn) 125 Free Float (%) 37 Shares O/S (mn) 726

Jubilant FoodWorks. Institutional Equity Research. Sector - FMCG. RSec TradEdge India. January 17, 2017

HG Infra Engineering Ltd.

SUBSCRIBE to H.G. Infra Engineering Ltd. Strong player in government s renewed focus sector

KEC International Ltd.

Apollo Micro Systems Ltd

Hindustan Media Ventures

Power Mech Projects. Institutional Equities. 2QFY19 Result Update BUY. Strong Order Book Drives Robust Execution

Inox Wind BUY. Performance Highlights. CMP Target Price `390 `505. 2QFY2016 Result Update Capital Goods. 3 year price chart

Strides Arcolab. Inline 4Q, recent acquisitions to deepen asset growth. Institutional Equity Research. Strides Arcolab. Pharmaceuticals India

GMM Pfaudler Limited BUY. Performance Update CMP. `945 Target Price ` QFY2019 Result Update Industrial Machinery. Investment Period 12 Months

Inox Wind BUY. Performance Highlights. CMP Target Price `242 `286. 4QFY2016 Result Update Capital Goods. 3 year price chart

Visaka Industries Ltd

CCL Products BUY. Brewing Steadily. CMP Target Price `300 `360. Initiating Coverage Coffee. January 4, year price chart

Simplex Infrastructures

Kalpataru Power. Rating: Target price: EPS: Rating CMP. Target BUY. Rs Rs.256

Garware Wall Ropes ACCUMULATE. Performance Highlights CMP. `550 Target Price `618. 2QFY2017 Result Update Textile. Investment Period 12 months

Parag Milk Foods BUY. Performance Update CMP. `256 Target Price `330. 2QFY2019 Result Update Dairy Products. Investment Period 12 Months

Fineotex Chemical Ltd

Quick take. Ruchira Papers Ltd. BUY. Creating value through paper. Target Price. Investment Period 12 Months. 3 year daily price chart.

Newgen Software Technologies Ltd

Sonata Software BUY. Laying the Platform for Growth. Institutional Equity Research. December 01, Target Price Rs185.

Robust results, TLT margins improved profitability.

Skipper Ltd. May 17, Towering high. CMP INR 205 Target INR 238 Result Update - BUY. Company Background. Investment Rationale

Key estimate revision. Financial summary. Year FY14 391,088 45,198 34, FY15E 354,262 35,426 23,

Ahluwalia Contracts (India)

Balkrishna Industries

Parag Milk Foods BUY. Performance Update CMP. `324 Target Price `410. 1QFY2019 Result Update Dairy Products. Investment Period 12 Months

ITC ACCUMULATE. Performance Highlights CMP. `257 Target Price `284. 3QFY2017 Result Update FMCG. Investment Period 12 Months

Bharat Dynamics Ltd SUBSCRIBE. Issue Open: Mar 13, 2018 Issue Close: Mar 15, IPO Note Defence. Key Financials

Sadbhav Infrastructure Project Ltd.

Gillette India. Institutional Equities. 2QFY19 Result Update BUY. Marketing Investments Mask Improved Top-line Performance

Greenply Industries BUY. The plywood maker for growing India. Target Price. Initiating Coverage Plywood. 3-year price chart.

Avenue Supermarts Limited

Blue Star Ltd BUY. Performance Update. CMP Target Price `703 `867. 1QFY2019 Result Update Cons. Durable. 3-year price chart.

Colgate-Palmolive (India)

Music Broadcast BUY. Performance Update. CMP Target Price `329 `475. 2QFY2019 Result Update Media. Historical share price chart.

Amber Enterprises India Ltd

Maruti Suzuki India BUY. Performance Update. CMP `9,315 Target Price `10,820. 1QFY2019 Result Update Automobile. Historical share price chart

Dilip Buildcon Ltd.: Q3FY18 Result Update

Power Mech Projects. Institutional Equities. 2QFY18 Result Update BUY. Strong Business Scalability Likely; Retain Buy

Wipro. 4QFY18 Result Update. Still not of the woods, maintain Hold. Sector: Technology CMP: ` 287. Recommendation: Hold

Gillette India. Institutional Equities. 1QFY18 Result Update

HCC BUY. Infrastructure April 10, QIP step in the right direction EVENT UPDATE. India Research. Bloomberg: HCC IN Reuters: HCNS.

NEUTRAL. Neogen Chemicals Ltd. Issue Open: April 24, 2019 Issue Close: April 26, IPO Note Specialty Chemicals

Music Broadcast BUY. Performance Update. CMP Target Price `293 `475. 3QFY2019 Result Update Media. Stock Info Sector Market Cap (Rs cr) Media

SQS India BFSI Ltd HOLD. Impact of Macro Headwinds Still Hurting; Revenue from US May Pick up in FY18E

Geared for growth. HG Infra Engineering. Not Rated. Visit Note Construction HGINFRA IN

Cummins India Ltd Bloomberg Code: KKC IN

Initiating Coverage. Uflex Ltd.

Future Supply Chain Solutions Ltd

MARKET RECAP. Instrument Close

TV Today Network BUY. Performance Update CMP. `323 Target Price `498. 3QFY2019 Result Update Media. Investment Period 12 Months

Consolidated Sales (Cr) Growth EBITDA (Cr) Margin PAT Margin EPS (Rs) P/E RoE

Mahindra & Mahindra Ltd.

Institutional Equities

Techno Electric & Engineering Limited

Skipper Ltd. February 13, Towering high. CMP INR 153 Target INR 184 Result Update - BUY. Company Background. Investment Rationale

KDDL (KDDL IN) In expansion mode

Coal India ACCUMULATE. Performance Highlights CMP. `338 Target Price `380. Outlook and valuation. 2QFY2016 Result Update Mining

Dilip Buildcon Ltd. 1 P a g e. Stock Details. Dilip Buildcon 2.1% Sensex 0.9%

Transcription:

Infrastructure India Initiating Coverage March 19, 2018 Market Cap. (Rs bn) 19.6 Free Float (%) 26 Shares O/S (mn) 65 Moving towards the Big League (HGI), a newly listed company, is primarily engaged in EPC, civil construction works and related infrastructure projects on item rate and lump sum basis. Roads & Highways segment which is HGI s key area of operation forms a dominant portion of its total order book. While current order book of Rs50.6bn (4.8x FY17 revenue) provides robust growth visibility, HGI is expected to add big chunk of orders to its kitty, led by improvement in financial prequalification and enormous opportunity in Roads & Highway segment. Further, diversification into newer geographies and water segment is likely to propel HGI to sustain growth, in our view. Expecting HGI s revenue and earnings to clock 31% and 46% CAGR, respectively through FY17-FY20E, we initiate coverage on the stock recommendation and one-year Target Price of Rs375. CAGR (FY17-20E) Revenue EBITDA PAT 31% 38% 46% Huge Opportunity in Roads & Highway Segment Augurs Well The visible development in Roads & Highways space along with likely further pick-up in projects awarding across the country and government s increased allocation for the segment are likely to aid HGI to improve its order book further. Further, improvement in financial pre-qualification post the fund raising through IPO is expected to result in higher order book in coming quarters. Impressive Order Book Growth Offers Visibility HGI witnessed an exponential improvement in its order book to Rs40bn in FY17 from Rs11bn in FY15 (94% CAGR). Its current order book at Rs50.6bn (4.8x of FY17 revenue) including L1 of Rs13.5bn provides a healthy revenue visibility. We expect HGI to witness an order inflow of Rs25bn and Rs30bn for FY19E and FY20E, respectively. Considering fund-based limit of Rs4.3bn and non-fund based limit of Rs5.0bn, we believe it should not face any financial constraint to execute the current order book. Shareholding Pattern (%) Dec'17 Post IPO Promoter 100 74 Public - 26 Diversification into New Geographies Bodes Well In order to mitigate concentration risk and exploit the upcoming infrastructure opportunities in other geographies, HGI has been geographically diversifying for last couple of quarters. It currently operates in six states including Uttar Pradesh and it intends to selectively expand into other states, which is expected to aid HGI to sustain growth, going forward. Promising Growth on the Cards; Initiate with HGI has been gaining a healthy traction for last two years on the backdrop of consistent order book addition and improving execution expertise. Further, with the improvement in financial pre-qualification post fund raising and enormous opportunity in its key vertical, we expect HGI s revenue and earnings to clock 31% and 46% CAGR, respectively through FY17-FY20E. While HGI did not provide any listing gain to its subscribers, we believe current valuations at 17.3x / 12.9x EPS of FY19E / FY20E, respectively, look attractive considering less than 1x PEG ratio and strong return ratios. Hence, we initiate our coverage on the stock with recommendation and one-year Target Price of Rs375 (16x FY20 EPS). Key Financials (Rs mn) FY17 FY18E FY19E FY20E Sales 9,703 12,615 16,798 21,606 EBITDA 1,198 1,774 2,402 3,122 Net Profit 493 782 1,132 1,524 EPS (Rs) 7.6 12.0 17.4 23.4 DPS (Rs) - - 2.0 3.0 P/E (x) 39.8 25.1 17.3 12.9 P/B (x) 3.1 3.5 3.0 2.5 EV/EBITDA 6.2 11.8 8.7 6.8 RoE (%) 33.0 21.4 18.8 21.3 Divi. Yield (%) - - 0.7 1.0 Source: Company, RSec Research Research Analyst: Binod Modi Contact: 022 3320 1097 Email: binod.modi@relianceada.com 1

Investment Rationale Huge Opportunity in Roads & Highway Segment Augurs Well The visible development in Roads & Highways space along with likely further pick-up in projects awarding across the country and government s increased allocation for the segment are likely to aid HGI to improve its order book further. Moreover, improvement in financial pre-qualification post the fund raising through IPO is expected to result in higher order book in coming quarters. Notably, budgetary allocation for Roads & Highways increased at a robust 20.9% CAGR through FY09-FY19. In Union Budget 2018-19, the Government has allocated Rs1.21trln (US$18.7bn) for the Road sector. Exhibit 1: Outlays for Roads & Highways in Union Budgets 20.0 Exhibit 2: Projects Awarded by NHAI 7,000 16.0 18.7 6,000 6,491 6,397 12.0 14.5 14.7 5,000 4,000 5,167 5,000 4,335 8.0 4.0 0.0 8.0 7.8 6.6 6.5 7.1 2.8 3.5 3.2 FY09 FY10 FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 3,000 2,000 1,000-3,368 1,435 1,165 643 FY09 FY10 FY11 FY12 FY13 FY14 FY15 FY16 FY17 Outlays (US$ bn) Awarded (kms) Source: Industry; RSec Research Impressive Order Book Growth Offers Visibility Consistent improvement in execution expertise along with improvement in technical and financial pre-qualification criterion enabled HGI to grow its order book exponentially to Rs40bn in FY17 from Rs11bn in FY15 (94% CAGR). Its current order book at Rs50.6bn (4.8x of FY17 revenue) including L1 of Rs13.5bn provides a healthy revenue visibility, in our view. HGI is currently pre-qualified to bid for Roads & Highway projects of NHAI and Ministry of Road Transport & Highways worth up to Rs8bn on in own. We expect HGI to add orders worth Rs25bn and Rs30bn for FY19E and FY20E, respectively, as against the Management s guidance of Rs30bn and Rs40bn, respectively. Notably, 44% of HGI s total order book is fixed price contracts and Rs1bn of orders book (2% of OB) comes from the JV. Further, HGI has recently secured a HAM project (part of L1) worth Rs5.6bn in Rajasthan. While HGI is still pursuing select HAM projects, it expects share of HAM projects in order book to contain within the range of 25%. Considering fund-based limit of Rs4.3bn and non-fund based limit of Rs5.0bn, we believe it should not face any financial constraint to execute the current order book. 2

Exhibit 3: Order Book Witnessed Robust Growth Exhibit 4: Top 5 Projects Under Execution 70.0 60.0 50.0 40.0 30.0 20.0 10.0-62.9 54.8 46.6 40.2 14.5 10.7 FY15 FY16 FY17 FY18E FY19E FY20E Order Book (Rs bn) Projects Appointed Date Value (Rs bn) Gulabpura- Chittorgarh Section-2 Nov-17 6.4 Chittorgarh- Udaipur Section of NH-76 Sec- 1 Jul-17 4.8 Nagpur-Katol- Warud State Highway Jun-17 3.1 Nandurbar - Prakasha- Sahada-Khetia State Highway Jun-17 3.0 Amaravati-Nandgaon-Morshi-warud- Pandhurna Jun-17 2.9 Exhibit 5: Segmental Break-up of Order Book (%) Exhibit 6: Clientele Break-up of Order Book (%) Water Projects, 2 Private, 23 Roads & Highways, 98 Government, 77 Diversification into New Geographies Bodes Well In order to mitigate the risk of excessive dependence on particular geography and exploit the upcoming infrastructure opportunities in other geographies, HGI has been geographically diversifying for last couple of quarters. It currently operates in six states including Uttar Pradesh and it intends to selectively expand its presence in other states. It currently expects that a significant portion of its geographic expansion will be in states i.e. Gujarat, Punjab and Madhya Pradesh, where it has favourable geographic and climatic conditions. Through further diversification of geographical operations, HGI is expected to hedge against concentration and related risks. Exhibit 7: A Snapshot of Statewise Order Book States Order Book (Rs bn) % of OB Rajasthan 26.7 52.8 Uttar Pradesh 0.5 1.1 Haryana 5.8 11.6 Uttarakhand 0.5 1.0 Maharashtra 16.6 32.7 Arunachal Pradesh 0.4 0.9 Total 50.6 100 3

Foray into Water Segment Augurs Well While HGI has proven its expertise in Roads & Highway segment by successfully executing various projects over the years, it has diversified into water pipeline segment and is currently undertaking 2 water supply projects on turnkey basis in Rajasthan. Renewed thrust of the Government on both the segments offers enormous opportunities for HGI. While the opportunities in Roads & Highways segments are already visible, we may see a robust ordering from irrigation, waterways and development of smart cities, going forward. Hence, any potential up-tick in order inflow from this segment is expected to aid HGI to witness a sustainable growth, in our view. Robust Financial Performance & Financial Strength An experienced management team, efficient working capital management, consistent addition of quality orders and prudent bidding strategy aided HGI to report robust numbers over the last 3 years. HGI s reported revenue and PAT clocked 30% and 42% CAGR, respectively over FY14-FY17. Further, light balance-sheet with efficient working capital management and asset-light business model enabled HGIE to generate better-than-the-industry average return ratios in the range of 30-40% over last 3 years. We believe that with the possible improvement in order book size with more geographies and segmental diversification and huge imminent opportunities in Roads & Highways and water pipeline projects, HGI is expected to report a consistent healthy growth, going forward. Revenue, EBITDA and PAT are expected to witness 31%, 39% and 46% CAGR, respectively through FY17-FY20E. Notably, HGI s EBITDA margin significantly spiked in 1HFY18 due to new accounting standard, as revenue booking is done net off indirect taxes. Further, gradual shift from a prime sub-contractor to a lead contractor also aided margin expansion. We expect the same to remain in the range of 14-15% over the years. Exhibit 8: Revenue Profile Over the Years 25.0 20.0 21.6 15.0 16.8 10.0 12.6 9.7 5.0 7.1 4.4 3.4 0.0 FY14 FY15 FY16 FY17 FY18E FY19E FY20E Revenue (Rs bn) Exhibit 9: Net Profit and Margins Over the Years 1,600 1,400 7.1 6.7 6.2 1,200 1,524 5.1 1,000 1,132 4.2 3.9 800 600 2.8 782 400 493 200 302 172 92 - FY14 FY15 FY16 FY17 FY18E FY19E FY20E PAT (Rs mn) Net Margin (%) 8.0 7.0 6.0 5.0 4.0 3.0 2.0 1.0 0.0 Exhibit 10: EBITDA and Margins Over the Years 3,500 14.5 14.3 14.1 3,000 2,500 13.1 2,000 12.4 1,500 3,122 11.4 2,402 1,000 11.0 1,774 500 1,198 781 506 439 - FY14 FY15 FY16 FY17 FY18E FY19E FY20E EBITDA (Rs mn) EBITDA Margin (%) 14.8 14.0 13.2 12.4 11.6 10.8 10.0 Exhibit 11: Snapshot of Return Ratios 48 43 40 33 32 29 27 28 26 24 23 23 24 21 21 19 17 16 11 8 0 FY14 FY15 FY16 FY17 FY18E FY19E FY20E ROCE (%) RoE (%) 4

Key Risks ff Higher dependence on road projects. ff Execution risk due to regulatory and social interferences. ff Cost overrun as 44% of total order book are fixed price contracts. ff Higher contingent liabilities (>200% of net worth). Exhibit 12: Peers Comparison Revenue (Rs bn) EBITDA Margin (%) PAT (Rs bn) PE (x) RoE (%) FY19E FY20E FY19E FY20E FY19E FY20E FY19E FY20E FY19E FY20E KNR Construction 22.0 25.7 16.9 17.4 2.4 2.4 17.2 17.2 19.4 16.4 Dilip Buildcon 83.2 97.1 18.6 18.2 6.9 8 19.1 16.8 25.2 22.9 J Kumar Infra 23.4 28.0 16.2 16.4 1.7 2.4 13.1 9.7 11.2 13.6 JMC Projects 32.3 36.7 10.2 10.1 1.2 1.4 16.3 13.8 13.8 14.6 PNC Infra. 26.4 35.8 13.6 13.7 2.1 2.6 18.9 15.2 11.1 12.3 HG Infra 16.8 21.6 14.3 14.5 1.1 1.5 17.3 12.9 18.8 21.3 Source: Bloomberg, RSec Research 5

Company Overview The Company was incorporated on January 21, 2003 as HG Infra Engineering Pvt. Ltd. Pursuant to the conversion of it to a public limited company, its name was changed to HG Infra Engineering Ltd. (HGI) on June 8, 2017. HGI is an infrastructure construction, development and management company with extensive experience in road projects including highways, bridges and flyovers. Its main business operations include: (i) providing Engineering, Procurement & Construction (EPC) services on a fixed-sum turnkey basis and; (ii) undertaking civil construction and related infrastructure projects on item rate and lump-sum basis, primarily in the road and highway sector. It has also forayed into executing water pipeline projects and is currently undertaking two water supply projects in Rajasthan on turnkey basis. Exhibit 13: Company Milestones Source: Company 6

Profit & Loss Statement Y/E Mar (Rs mn) FY17 FY18E FY19E FY20E Income 9,703 12,615 16,798 21,606 % yoy growth 36.2 30.0 33.2 28.6 Operting Expenses 8,505 10,841 14,396 18,484 EBIDTA 1,198 1,774 2,402 3,122 EBIDTA Margin (%) 12.4 14.1 14.3 14.5 Depreciation & Amortization 256 370 500 615 Finance Costs 193 261 281 286 Other Income 37 42 93 88 PBT before excep items 786 1,185 1,715 2,308 Extraordinary Items - - - PBT 786 1,185 1,715 2,308 Tax 294 403 583 785 % Tax 37.3 34.0 34.0 34.0 Net Profit- Reported 493 782 1,132 1,524 YoY Growth (%) 63.3 58.7 44.7 34.6 Net Profit Margin (%) 5.1 6.2 6.7 7.1 Balance Sheet Y/E Mar (Rs mn) FY17 FY18E FY19E FY20E Sources of Funds Share Capital 180 652 652 652 Reserves & Surplus 1,579 4,889 5,865 7,154 Total Shareholder's funds 1,759 5,541 6,516 7,805 Borrowings 2,037 2,500 2,600 2,600 Non- Current Liabilities 303 402 529 691 Current Liabilities 1,282 1,761 3,264 4,261 Total Liabilities 5,380 10,203 12,909 15,358 Application of Funds Gross Fixed Assets 3,011 4,211 5,311 6,411 Less: Acc. Depreciation 967 1,337 1,837 2,453 Net Fixed Assets 2,044 2,874 3,474 3,958 CWIP 7 350 250 150 Deferred Tax Assets (Net) 20 22 22 22 NC Investments 4 5 505 1,005 Inventories 489 917 1,209 1,578 Sundry Debtors 1,132 1,529 2,015 2,630 Other Current Assets 596 1,834 2,216 2,630 Cash & Bank Balances 72 1,207 1,328 940 Loans & Advances 782 1,038 1,368 1,786 Toal Current Assets 3,070 6,525 8,135 9,565 Other Non-Current Assets 235 428 524 658 Total Assets 5,380 10,203 12,909 15,358 7

Cash Flow Statement Y/E Mar (Rs mn) FY17 FY18E FY19E FY20E PBT 830 1,185 1,715 2,308 Depreciation 256 370 500 615 Net Change in Working Capital (479) (1,934) 46 (792) Others (4) - - - Interest 189 261 281 286 Tax Paid (246) (405) (583) (785) Net Cash from Operating Activities 544 (523) 1,958 1,633 Capex (1,151) (1,543) (1,000) (1,000) Sale / (Purchase) of Investments (75) - - - Others 93 (1) (500) (500) Net Cash used in Investing Activities (1,134) (1,544) (1,500) (1,500) Borrowings (Net) 809 463 100 - Issue of Share Cap. - 3,360 - - Dividend Paid - - (156) (235) Finance Cost (189) (261) (281) (286) Others - (360) - - Net Cash used in Financing Activities 620 3,203 (337) (521) Net Increase/ (Decrease) in Cash 31 1,135 121 (388) Key Ratios Y/E Mar FY17 FY18E FY19E FY20E Valuation Ratio (x) P/E 39.8 25.1 17.3 12.9 P/CEPS 26.2 17.0 12.0 9.2 P/BV 3.1 3.5 3.0 2.5 EV/EBIDTA 6.2 11.8 8.7 6.8 EV/Sales 0.8 1.7 1.2 1.0 Dividend Payout (%) - - 11.5 12.8 Dividend Yield (%) - - 0.7 1.0 Per Share Data (Rs) EPS (Basic) 7.6 12.0 17.4 23.4 EPS (Diluted) 7.6 12.0 17.4 23.4 CEPS 11.5 17.7 25.0 32.8 DPS - - 2.0 3.0 Book Value 98 85 100 120 Returns (%) RoCE 27.7 23.3 23.0 26.3 RoE 33.0 21.4 18.8 21.3 Turnover ratios (x) Asset Turnover (Gross block) 3.2 3.0 3.2 3.4 Inventory (days) 21 30 30 30 Receivables (days) 49 50 50 50 Payables (days) 27 27 28 28 WCC (days) 43 53 52 52 8

Rating Guides Rating Expected absolute returns (%) over 12 months >10% HOLD -5% to 10% REDUCE >-5% Reliance Securities Limited (RSL), the broking arm of Reliance Capital is one of the India s leading retail broking houses. Reliance Capital is amongst India s leading and most valuable financial services companies in the private sector. Reliance Capital has interests in asset management and mutual funds, life and general insurance, commercial finance, equities and commodities broking, wealth management services, distribution of financial products, private equity, asset reconstruction, proprietary investments and other activities in financial services. The list of associates of RSL is available on the website www.reliancecapital.co.in. RSL is registered as a Research Analyst under SEBI (Research Analyst) Regulations, 2014 General Disclaimers: This Research Report (hereinafter called Report ) is prepared and distributed by RSL for information purposes only. The recommendations, if any, made herein are expression of views and/or opinions and should not be deemed or construed to be neither advice for the purpose of purchase or sale of any security, derivatives or any other security through RSL nor any solicitation or offering of any investment /trading opportunity on behalf of the issuer(s) of the respective security(ies) referred to herein. These information / opinions / views are not meant to serve as a professional investment guide for the readers. No action is solicited based upon the information provided herein. Recipients of this Report should rely on information/data arising out of their own investigations. Readers are advised to seek independent professional advice and arrive at an informed trading/investment decision before executing any trades or making any investments. This Report has been prepared on the basis of publicly available information, internally developed data and other sources believed by RSL to be reliable. RSL or its directors, employees, affiliates or representatives do not assume any responsibility for, or warrant the accuracy, completeness, adequacy and reliability of such information / opinions / views. While due care has been taken to ensure that the disclosures and opinions given are fair and reasonable, none of the directors, employees, affiliates or representatives of RSL shall be liable for any direct, indirect, special, incidental, consequential, punitive or exemplary damages, including lost profits arising in any way whatsoever from the information / opinions / views contained in this Report. Risks: Trading and investment in securities are subject to market risks. There are no assurances or guarantees that the objectives of any of trading / investment in securities will be achieved. The trades/ investments referred to herein may not be suitable to all categories of traders/investors. The names of securities mentioned herein do not in any manner indicate their prospects or returns. The value of securities referred to herein may be adversely affected by the performance or otherwise of the respective issuer companies, changes in the market conditions, micro and macro factors and forces affecting capital markets like interest rate risk, credit risk, liquidity risk and reinvestment risk. Derivative products may also be affected by various risks including but not limited to counter party risk, market risk, valuation risk, liquidity risk and other risks. Besides the price of the underlying asset, volatility, tenor and interest rates may affect the pricing of derivatives. Disclaimers in respect of jurisdiction: The possession, circulation and/or distribution of this Report may be restricted or regulated in certain jurisdictions by appropriate laws. No action has been or will be taken by RSL in any jurisdiction (other than India), where any action for such purpose(s) is required. Accordingly, this Report shall not be possessed, circulated and/ or distributed in any such country or jurisdiction unless such action is in compliance with all applicable laws and regulations of such country or jurisdiction. RSL requires such recipient to inform himself about and to observe any restrictions at his own expense, without any liability to RSL. Any dispute arising out of this Report shall be subject to the exclusive jurisdiction of the Courts in India. Disclosure of Interest: The research analysts who have prepared this Report hereby certify that the views /opinions expressed in this Report are their personal independent views/opinions in respect of the securities and their respective issuers. None of RSL, research analysts, or their relatives had any known direct /indirect material conflict of interest including any long/short position(s) in any specific security on which views/opinions have been made in this Report, during its preparation. RSL s Associates may have other potential/material conflict of interest with respect to any recommendation and related information and opinions at the time of publication of research report. RSL, its Associates, the research analysts, or their relatives might have financial interest in the issuer company(ies) of the said securities. RSL or its Associates may have received a compensation from the said issuer company(ies) in last 12 months for the brokerage or non brokerage services.rsl, its Associates, the research analysts or their relatives have not received any compensation or other benefits directly or indirectly from the said issuer company(ies) or any third party in last 12 months in any respect whatsoever for preparation of this report. The research analysts has served as an officer, director or employee of the said issuer company(ies)?: No RSL, its Associates, the research analysts or their relatives holds ownership of 1% or more, in respect of the said issuer company(ies).?: No Copyright: The copyright in this Report belongs exclusively to RSL. This Report shall only be read by those persons to whom it has been delivered. No reprinting, reproduction, copying, distribution of this Report in any manner whatsoever, in whole or in part, is permitted without the prior express written consent of RSL. RSL s activities were neither suspended nor have defaulted with any stock exchange with whom RSL is registered. Further, there does not exist any material adverse order/judgments/ strictures assessed by any regulatory, government or public authority or agency or any law enforcing agency in last three years. Further, there does not exist any material enquiry of whatsoever nature instituted or pending against RSL as on the date of this Report. Important These disclaimers, risks and other disclosures must be read in conjunction with the information / opinions / views of which they form part of. RSL CIN: U65990MH2005PLC154052. SEBI registration no. ( Stock Brokers: NSE - INB / INF / INE 231234833; BSE - INB / INF / INE 011234839, Depository Participants: CDSL IN-DP-257-2016 IN-DP-NSDL-363-2013, Research Analyst: INH000002384); AMFI ARN No.29889. 9